Gulf Pharmaceutical Industries (Julphar) News - Mubasher Info
Palestine
Mubasher TV
 Contact Us Advertising   العربية
Palestine
PEX Pre Close
11 February 04:47 AM

Gulf Pharmaceutical Industries (JULPHAR)

Last update: 10 February 02:58 PM market time.
1.22
0.01
0.83%
Open 1.21
Previous Close 1.21
High 1.24
Low 1.20
Stock Statistics
Volume 3,181,915
Turnover 3,866,441.28
All data are 15 minutes late during market session

News

Photo Archive
14 August 2025 03:21 PM Julphar turns into profitability in H1-25 backed by operations in Egypt
Abu Dhabi - Mubasher: Gulf Pharmaceutical Industries (Julphar) swung to profitability at AED 158.20 million in the first half (H1) of 2025, against net losses of AED 2.40 million in H1-24. Basic and diluted earnings per share stood at 13.70 fils …
Financial Results
Photo Archive
17 November 2024 09:55 AM Julphar’s drives portfolio progress in MENA with 14% higher sales in 9M-24
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) recorded sales valued at AED 1.30 billion in the first nine months (9M) of 2024, higher by 14% year-on-year (YoY) than AED 1.22 billion. The ADX-listed frim posted lower net losses at …
Financial Results
Photo Archive
18 August 2024 11:13 AM Julphar sees lower net losses in H1-24; revenues up 3%
Abu Dhabi – Mubasher: The net losses of Gulf Pharmaceutical Industries (Julphar) retreated to AED 2.40 million in the first half (H1) of 2024 from AED 45.70 million in H1-23. The revenues from contracts with customers stood at AED 883.10 million …
Financial Results
Photo Archive
15 May 2024 09:37 AM Julphar turns profitable in Q1-24; accumulated losses announced
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) logged net profits attributable to the owners amounting to AED 1.90 million in the first quarter (Q1) of 2024. The registered profits were compared to net losses worth AED 2.90 million …
Financial Results
Photo Archive
17 March 2024 00:28 PM Julphar’s 2023 accumulated losses hit 30% of capital; revenues up
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) registered accumulated losses valued at AED 346.70 million as of 31 December 2023. The incurred accumulated losses represent 30% of the company’s paid-up capital, according to a bourse …
Financial Results
Photo Archive
13 November 2023 00:47 PM Julphar turns to losses in 9M-23; accumulated losses reach 29% of capital
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) shifted to net losses attributable to the equityholders amounting to AED 83.40 million in the first nine months (9M) of 2023. The negative results were compared to net profits worth …
Financial Results
Photo Archive
14 August 2023 10:53 AM Julphar unveils H1-23 financials; accumulated losses hit AED 295.5m
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) swung to net losses attributable to the owners valued at AED 44.10 million in the first half (H1) of 2023, versus profits of AED 6.30 million in H1-22. The revenues from contracts with …
Financial Results
Photo Archive
17 May 2023 08:26 AM Julphar shifts to losses in Q1-23; accumulated losses unveiled
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) turned to net losses attributable to the shareholders worth AED 2.90 million in the first quarter (Q1) of 2023. The incurred net losses were against profits valued at AED 1.50 million …
Financial Results
Photo Archive
9 February 2023 05:03 PM Julphar’s CEO resigns; Ziyadeh assumes position
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) announced, on 9 February, the resignation of Essam Mohamed from his position as the CEO of the company. Julphar elaborated that Mohamed left the firm as he will join another company, …
Board of Directors
Photo Archive
10 November 2022 04:07 PM Julphar’s profits to equityholders shrink to AED 10.5m in 9M-22
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) logged net profits attributable to the owners worth AED 10.40 million in the first nine months (9M) of 2022, down from AED 103.20 million in 9M-21. Revenue from contracts with …
Financial Results
Photo Archive
16 May 2022 08:41 AM Julphar turns to profitability in Q1-22
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) has achieved net profits attributable to the equity holders of AED 1.5 million in the first quarter (Q1) of 2022, against net losses of AED 23.9 million in the same quarter of 2021, …
Financial Results
Photo Archive
20 March 2022 09:09 AM Julphar turns to profitability in 2021
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) has achieved net profits attributable to the equity holders of AED 64.4 million in 2021, against net losses of AED 293.2 million in 2020, according to the company's consolidated …
Financial Results
Photo Archive
6 December 2021 09:19 AM Julphar inks exclusive license, production agreement with France's Quantum Genomics
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) has reached an exclusive license and production agreement with Quantum Genomics, a France-based biopharmaceutical company, to market and produce firibastat. Through its manufacturing …
Companies Investments
Photo Archive
28 November 2021 08:38 AM Julphar logs AED 183m accumulated losses
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) has incurred accumulated losses of AED 183.1 million as of the third quarter (Q3) of 2021, representing 16% of the capital. The losses are driven by the temporary suspension of export …
Financial Results
Gulf Inject is specialised in fluid management therapy
5 September 2021 03:23 PM Julphar sells 100% subsidiary Dubai-based Gulf Inject
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) has entered into an agreement to sell its wholly-owned subsidiary, Dubai-based Gulf Inject, to GlobalOne Healthcare Holding, the healthcare division of Yas Holding in Abu Dhabi. The …
Companies Investments
Photo Archive
15 August 2021 02:58 PM Julphar turns profitable in H1-21
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) registered AED 49.9 million in profits during the first half (H1) of the year, compared with losses of AED 83.2 million in H1-20. The company attributed turning profitable to the …
Financial Results
Julphar has previously held a 40% stake in the company
13 July 2021 03:12 PM Julphar fully acquires Planet Pharmacies
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) has entered into an agreement to fully acquire Planet Pharmacies, one of the leading pharmaceutical distributors in the UAE, Saudi Arabia, and the Sultanate of Oman. Julphar, which …
Companies Investments
The transaction is expected to reduce 10% to 12% of Julphar's consolidated total assets
16 June 2021 03:18 PM Julphar sells 51% stake in Alpha Pharma
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) has sold its 51% stake in Alpha Pharma. Expected to be completed in the third quarter (Q3) of 2021, the transaction is expected to reduce 10% to 12% of Julphar's consolidated total …
Companies Investments
The vaccine production's financial impact will appear from 2021 onwards
29 March 2021 09:29 AM Julphar inks agreement to manufacture COVID-19 vaccines from Sinopharm
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) has entered into a manufacturing agreement with G42 Medications Trading to produce the coronavirus (COVID-19) vaccines from China's Sinopharm. The commercial production of the …
Companies Investments
The company has completed a capital reduction
12 August 2020 08:54 AM Julphar logs AED 83m accumulated losses
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) posted AED 83.2 million accumulated losses as of the end of the second quarter (Q2) of 2020, representing 12.7% of the capital. The accumulated losses are driven by the temporary …
Financial Results
The company will implement its growth plans
15 July 2020 01:03 PM Julphar's rights issue oversubscribed 2.3 times
Abu Dhabi – Mubasher: The AED 500 million rights issue of Gulf Pharmaceutical Industries (Julphar) has been oversubscribed 2.3 times to settle at AED 1.14 billion on application which closed on 12 July. The net proceeds from the rights issue will …
Corporate Actions
The company will issue 500 million new shares
1 June 2020 10:36 AM Julphar launches AED 500m rights issue to improve capital profile
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) has launched a rights issue to raise AED 500 million and improve its capital position and debt profile. By raising AED 500 million, the company will finance its turnaround plan and put …
Management Decisions
Selling and distribution expenses dropped to AED 49.1 million
27 May 2020 03:20 PM Julphar’s loss down 30% in Q1-20; accumulated losses at AED 566m
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) incurred AED 62.5 million in net losses attributable to shareholders during the first quarter of 2020, down from AED 89.1 million in the year-ago period. Net sales fell to AED 114.6 …
Financial Results
The company will start exporting over 100 products to Saudi Arabia
30 April 2020 11:06 AM Julphar to resume exports to Saudi Arabia after two-year suspension
Abu Dhabi – Mubasher: The Saudi Food and Drug Authority (SFDA) has lifted the temporary suspension on the exports of Gulf Pharmaceutical Industries (Julphar) to Saudi Arabia. Following a ban for 20 months, Julphar's exports to Saudi Arabia will be …
Companies Investments
Losses are driven by the suspension of exports to Saudi Arabia, Oman, and Kuwait
9 April 2020 09:39 AM Julphar to extinguish accumulated losses via capital cut
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) plans to decrease the share capital by AED 503.274 million by canceling a number of the company's shares. With the capital reduction, Julphar seeks to write off accumulated losses …
Corporate Actions